NO995940D0 - Use of leptin antagonists for the treatment of diabetes - Google Patents

Use of leptin antagonists for the treatment of diabetes

Info

Publication number
NO995940D0
NO995940D0 NO995940A NO995940A NO995940D0 NO 995940 D0 NO995940 D0 NO 995940D0 NO 995940 A NO995940 A NO 995940A NO 995940 A NO995940 A NO 995940A NO 995940 D0 NO995940 D0 NO 995940D0
Authority
NO
Norway
Prior art keywords
diabetes
treatment
leptin antagonists
leptin
antagonists
Prior art date
Application number
NO995940A
Other languages
Norwegian (no)
Other versions
NO995940L (en
Inventor
Michael Cawthorne
Valur Emilsson
Yong-Ling Liu
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP1997/002240 external-priority patent/WO1998055139A1/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Priority to NO995940A priority Critical patent/NO995940L/en
Publication of NO995940D0 publication Critical patent/NO995940D0/en
Publication of NO995940L publication Critical patent/NO995940L/en

Links

NO995940A 1997-06-06 1999-12-03 Use of leptin antagonists for the treatment of diabetes NO995940L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO995940A NO995940L (en) 1997-06-06 1999-12-03 Use of leptin antagonists for the treatment of diabetes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP1997/002240 WO1998055139A1 (en) 1997-06-06 1997-06-06 Use of leptin antagonists for the treatment of diabetes
NO995940A NO995940L (en) 1997-06-06 1999-12-03 Use of leptin antagonists for the treatment of diabetes

Publications (2)

Publication Number Publication Date
NO995940D0 true NO995940D0 (en) 1999-12-03
NO995940L NO995940L (en) 2000-02-03

Family

ID=19904053

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995940A NO995940L (en) 1997-06-06 1999-12-03 Use of leptin antagonists for the treatment of diabetes

Country Status (1)

Country Link
NO (1) NO995940L (en)

Also Published As

Publication number Publication date
NO995940L (en) 2000-02-03

Similar Documents

Publication Publication Date Title
NO20006630D0 (en) Pharmaceutical composition for the treatment of diabetes
IS5113A (en) Use of CB1 antagonists for the treatment of craving disorders
NO991186L (en) Use of leptin antagonists for the treatment of insulin resistance in type II diabetes
NO20014379L (en) Use of Xenon for the Treatment of Neurointoxics
NO20022087L (en) Procedure for the treatment of diabetes
EE04190B1 (en) Use of substituted benzopyran derivatives for the treatment of inflammation
NO974554L (en) Procedure for the treatment of an underground formation
NO20063000L (en) Combination and pharmaceutical composition for the treatment of diabetes and its use.
HUP0003428A3 (en) Use of leptin antagonists for the treatment of diabetes
NO20005179D0 (en) Drug treatment
NO995831D0 (en) Injectable, clear formulation of an anesthetic agent
NO20001847L (en) New use of compounds for anti-itch activity
NO983090D0 (en) Therapeutic compounds
NO994258L (en) Use of levobupivacaine for the treatment of facial migraines
PT964867E (en) ANTAGONISTS OF THE TAQUICINIMA
NO20005386L (en) Use of NMDA antagonists for the treatment of irritable bowel syndrome
NO20003481D0 (en) Procedure for the treatment of COPD
NO20001894L (en) Use of TNF antagonists as drugs for the treatment of septic diseases
NO20012612L (en) Isonipecotamides for the treatment of integrin-mediated diseases
NO993549L (en) Imino-aza-anthracycline derivatives for the treatment of amyloidosis
NO20002481D0 (en) Combination therapy for the treatment of AIDS
NO995940D0 (en) Use of leptin antagonists for the treatment of diabetes
NO985558D0 (en) New improved formulation for the treatment of thromboembolism
ID24439A (en) USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT
DE69819503D1 (en) USE OF 7-APHA-METHYL-17-ALPHA-ETHYNYL-ESTRANE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSE

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application